Skip to main content
Accessibility|Contact|Privacy|Terms of Service

Scalp Cooling Offers Safe Effective Method for Preventing Hair Loss During Chemotherapy

  • Published: 2016-06-02 : Author: Paxman : Contact:
  • Synopsis: Scalp cooling is a safe, feasible and an effective treatment in the prevention of chemotherapy induced alopecia.

Main Document

"The Paxman scalp cooler is the world leading hair loss prevention system for chemotherapy patients..."

Scalp cooling is a safe, feasible and an effective treatment in the prevention of chemotherapy induced alopecia (CIA) according to a German study being presented at the American Society of Clinical Oncology Annual meeting (ASCO).

Dr Christian Kurbacher, Gynecologic Oncologist for Gynecologic Center Bonn-Friedensplatz will present the results of a study carried out on a Paxman scalp cooling system, at this year's annual meeting, one of the world's largest cancer platforms.

The abstract will reveal that 53% of patients that used the cold cap before, during and after chemotherapy completely retained their hair. A further 11% only experienced partial hair loss. It will also conclude that any side effects associated with scalp cooling were minor and were completely resolved once the cap had been removed.

The aim of the study was to assess the effectiveness of scalp cooling in the prevention of chemotherapy induced hair loss. It also looked to obtain detailed information about the safety of using the Paxman scalp cooler.

Speaking about the results Dr Kurbacher, said:

"Scalp cooling has been effective in many countries but it is not always used due to physicians´ concerns regarding safety and feasibility."

"Our study assessed this in more detail and we were delighted to confirm that the Paxman system offers a feasible, safe and effective treatment in the prevention of chemotherapy induced hair loss amongst breast cancer patients and in female genital tract carcinomas."

A second abstract about a US scalp cooling alopecia prevention trial (SCALP) will also be presented at congress by Dr Julie Nangia of the Baylor College of Medicine

The multi-center trial, taking place in Dallas, Houston, New Jersey and Ohio, aims to evaluate the safety and efficacy of the Paxman scalp cooler in reducing the incidence of chemotherapy-induced alopecia.

Two hundred and thirty five patients will be enrolled on the five-year study which will assess things such as overall survival, site of first recurrence and incidence of isolated scalp metastasis. Factors such as wig/scarf use and quality of life will also be mointored.

The Paxman scalp cooler is the world leading hair loss prevention system for chemotherapy patients. It has been used by over 100,000 patients in 32 countries and is responsible for helping patients keep their hair and retain normality during chemotherapy. The device was originally developed by a British entrepreneur after his wife underwent chemotherapy in the 1990s.

Hair loss is a well-known side effect of many chemotherapy regimens, with many patients claiming it is the most traumatic aspect of their treatment. Scalp cooling provides the only real alternative to hair loss resulting in a high level of retention or complete hair preservation, improving patients' self-confidence and creating positive attitudes towards treatment. It works by lowering scalp temperature before, during and after the administration of chemotherapy.

Made from lightweight, silicone tubing, the scalp-cooling cap is soft and flexible - providing a snug yet comfortable fitting cap during treatment. Moulding to all head shapes and sizes, liquid coolant passes through the cap extracting heat from the patient's scalp, ensuring the scalp remains at an even, constant temperature to minimize hair loss.

For more information about scalp cooling visit

Similar Topics

1 : Body Probe as Thin as a Hair Has Imaging Function and Temperature Sensor : University of Adelaide.
2 : Compact DreamStation CPAP Sleep Apnea Device Makes Travel Easier : Royal Philips.
3 : Ribcap Protective Hats For Fall Risk Patients : Disabled World.
4 : U.S. Access Board Issues New Standards for Medical Diagnostic Equipment : The White House, 1600 Pennsylvania Avenue, NW, Washington DC 20500, 202-456-1111.
5 : Scalp Cooling Offers Safe Effective Method for Preventing Hair Loss During Chemotherapy : Paxman.
From our Medical Devices section - Full List (40 Items)

Submit disability news, coming events, as well as assistive technology product news and reviews.

Loan Information for low income singles, families, seniors and disabled. Includes home, vehicle and personal loans.

Famous People with Disabilities - Well known people with disabilities and conditions who contributed to society.

List of awareness ribbon colors and their meaning. Also see our calendar of awareness dates.

Blood Pressure Chart - What should your blood pressure be, and information on blood group types/compatibility.

1 : Teaching Baby Sign Language - Nita, Show Us More
2 : MitoQ Novel Antioxidant Makes Old Arteries Seem Young Again
3 : Telemedicine Helps Overcome Healthcare Gender Based Barriers
4 : Screen Reader Plus Keyboard Helps Blind, Low-Vision Users Browse Modern Webpages
5 : Our Digital Remains Should be Treated with Same Care and Respect as Physical Remains
6 : Tungsten: Concern Over Possible Health Risk by Human Exposure to Tungsten
7 : Student Loan Discharge Process for Disabled Veterans Made Easier
8 : Growing Bone and Cartilage Tissues for Humans from Flaxseed Like Particles

Disclaimer: This site does not employ and is not overseen by medical professionals. Content on Disabled World is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. See our Terms of Service for more information.

Reporting Errors: Disabled World is an independent website, your assistance in reporting outdated or inaccurate information is appreciated. If you find an error please let us know.

© 2004 - 2018 Disabled World™